Overview

Effect of Ramosetron on Bowel Motility After Colorectal Resection

Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
0
Participant gender:
All
Summary
Ramosetron is effective in preventing postoperative nausea and vomiting. Several studies reported that ramosetron is also effective treatment diarrhea-predominant irritable bowel syndrome. The investigators examine the effect of ramosetron used for preventing postoperative nausea and vomiting on bowel motility.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kyunghee University Medical Center
Treatments:
Ramosetron
Criteria
Inclusion Criteria:

- 20-70 yr of age,

- ASA I or II,

- scheduled for laparoscopic colorectal surgery

Exclusion Criteria:

- antiemetic use within 24hr prior to surgery

- steroid use within 24hr prior to surgery or 48hr after surgery

- insulin dependent DM

- cardiovascular or pulmonary disease

- renal or hepatic insufficiency

- BMI >=35kg/m2

- pregnancy